KCNQ1 Gain-of-Function Mutation in Familial Atrial Fibrillation

Yi-Han Chen(Tongji University), Shi-Jie Xu(Shanghai Institute of Nutrition and Health), Saı̈d Bendahhou(Centre National de la Recherche Scientifique), Xiao-Liang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Ying Wang(Chinese National Human Genome Center at Shanghai), Wenyuan Xu(Tongji University), Hongwei Jin(Chinese Academy of Medical Sciences & Peking Union Medical College), Hao Sun(Chinese National Human Genome Center at Shanghai), Xiao-Yan Su(Tongji University), Qi-Nan Zhuang(Chinese National Human Genome Center at Shanghai), Yiqing Yang(Tongji University), Yue-Bin Li(Chinese National Human Genome Center at Shanghai), Yi Liu(Tongji University), Hong-Ju Xu(Tongji University), Xiaofei Li(Tongji University), Ning Ma(Tongji University), Chun-Ping Mou(Tongji University), Zhu Chen(Chinese National Human Genome Center at Shanghai), Jacques Barhanin(Centre National de la Recherche Scientifique), Wei Huang(Shanghai Institute of Nutrition and Health)
Science
January 9, 2003
Cited by 999

Abstract

Atrial fibrillation (AF) is a common cardiac arrhythmia whose molecular etiology is poorly understood. We studied a family with hereditary persistent AF and identified the causative mutation (S140G) in the KCNQ1 (KvLQT1) gene on chromosome 11p15.5. The KCNQ1 gene encodes the pore-forming alpha subunit of the cardiac I(Ks) channel (KCNQ1/KCNE1), the KCNQ1/KCNE2 and the KCNQ1/KCNE3 potassium channels. Functional analysis of the S140G mutant revealed a gain-of-function effect on the KCNQ1/KCNE1 and the KCNQ1/KCNE2 currents, which contrasts with the dominant negative or loss-of-function effects of the KCNQ1 mutations previously identified in patients with long QT syndrome. Thus, the S140G mutation is likely to initiate and maintain AF by reducing action potential duration and effective refractory period in atrial myocytes.


Related Papers